BioHybrid Technologies' Artificial Pancreas

---

Using current technology, the transplantation of human organs or cells to another human requires intensive immunosuppressive therapy, which seriously compromises the overall health of the recipient. An additional obstacle is the critical shortage of human organs or cells available for transplantation. Xenotransplantation of animal organs or cells into humans remains impossible even with extensive immunosuppression. BioHybrid Technologies pioneered cell encapsulation as a method for overcoming these challenges.